After his controversial nomination as HHS Secretary, all eyes were on Robert F. Kennedy, Jr. as he addressed a measles outbreak in Texas that has affected over 160 people across 10 states. NBC News Health & Medical Reporter Erika Edwards reports on this and the postponing of a key CDC meeting that could hold up the production of next year’s flu vaccine.

This week, the Food and Drug Administration — now with vaccine skeptic Robert F. Kennedy Jr. at the helm — unexpectedly and without reason canceled a March meeting of scientists who advise the FDA on vaccine policy. A similar meeting at the Centers for Disease Control was postponed last week.

The meeting cancellation came one day before the CDC issued its weekly MMWR report, a scientific update on the latest public-health news. In the Feb. 27 edition, CDC scientists published new data on the benefits of flu shots in protecting both children and adults from serious complications.

The Vaccines and Related Biological Products Advisory Committee was supposed to meet on March 13 to recommend to the agency which flu strains should be included in influenza shots for the Northern Hemisphere’s next flu season.

The U.S. Food and Drug Administration confirmed on Thursday that a meeting of its independent advisory panel to discuss the composition of this year's flu vaccine has been canceled and the regulator would instead make recommendations later.

The FDA’s abrupt decision to cancel next month’s vaccine advisory committee meeting is raising concerns about whether the U.S. will have enough of the vaccine for the next flu season.

The Food and Drug Administration unexpectedly canceled an annual meeting of its advisers to update next season's influenza vaccines, raising concerns about the timeline for manufacturing next winter's flu shots.